Tag: Assistant Director-General for Access to Medicines and Health Products

WHO Issues Warning on Falsified Medicines Used for Diabetes Treatment and Weight Loss

The World Health Organisation (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of Type 2 diabetes and obesity in some countries. The alert addresses three falsified batches of product of semaglutide class of medicines (of specific brand Ozempic), which were detected in Brazil, Great […]...